RBC Capital Maintains Outperform on Clarivate, Raises Price Target to $14
RBC Capital analyst Ashish Sabadra maintains Clarivate (NYSE:CLVT) with a Outperform and raises the price target from $12 to $14.
Why Novavax Shares Are Trading Lower By Around 28%? Here Are Other Stocks Moving In Wednesday’s Mid-Day Session
Gainers
Reata Pharmaceuticals Inc (NASDAQ: RETA) shares jumped 171.5% to $84.67 after the company reported the FDA approval of SKYCLARYS for patients with Friedreich's Ataxia.
3D Systems, CarGurus, Sarepta Therapeutics And Other Big Stocks Moving Higher On Wednesday
U.S. stocks traded lower, with the Dow Jones dropping around 80 points on Wednesday. Here are some big stocks recording gains in today’s session.
Earnings Scheduled For March 1, 2023
Companies Reporting Before The Bell
• Globalstar (AMEX:GSAT) is expected to report quarterly loss at $0.01 per share on revenue of $38.75 million.
Morgan Stanley Downgrades Clarivate to Equal-Weight, Raises Price Target to $12
Morgan Stanley analyst Toni Kaplan downgrades Clarivate (NYSE:CLVT) from Overweight to Equal-Weight and raises the price target from $11 to $12.
Expert Ratings for Clarivate
Clarivate (NYSE:CLVT) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish…
Morgan Stanley Maintains Overweight on Clarivate, Lowers Price Target to $11
Morgan Stanley analyst Toni Kaplan maintains Clarivate (NYSE:CLVT) with a Overweight and lowers the price target from $13 to $11.
Stocks That Hit 52-Week Lows On Thursday
Thursday's session saw 329 companies set new 52-week lows.
Stocks That Hit 52-Week Lows On Tuesday
Tuesday's session saw 184 companies set new 52-week lows.
Earnings Scheduled For November 8, 2022
Companies Reporting Before The Bell
• Adtran (NASDAQ:ADTN) is likely to report quarterly earnings at $0.18 per share on revenue of $330.39 million.